Plus Therapeutics | CYTX - Gross Profit On Sales

Stock Price
6.60
Daily Change
-0.68 -9.34%
Monthly
7.36%
Yearly
-66.49%
Q2 Forecast
6.46

Plus Therapeutics reported 1.37M in Gross Profit on Sales for its fiscal quarter ending in December of 2025.





Gross Profit On Sales Change Date
Baxter International USD 577M 373M Dec/2025
Cerus USD 33.33M 8.66M Dec/2024
Dr.Reddys Laboratories INR 51.37B 629M Dec/2025
Haemonetics USD 202.39M 7.64M Dec/2025
Infinity Pharmaceuticals USD 231K 59K Jun/2023
Plus Therapeutics 1.37M 30K Dec/2025
Sanofi EUR 8.45B 1.31B Dec/2025
Starpharma Holdings AUD -736K 2.82M Jun/2025
Sun Pharmaceuticals INR 107.66B 2.05B Sep/2025
Teva Pharmaceutical Industries USD 2.66B 351M Dec/2025